Daikin Industries Stock Surges 14% After Elliott Investment Management Discloses Major Stake 
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits 
Hermès Q1 2026 Sales Miss Expectations Amid Iran War and China Slowdown 
Japan Opens Arms Export Floodgates: New Policy Draws Global Defense Interest 
DEEPX Partners with Hyundai to Power Next-Gen AI Robots Ahead of IPO 
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million 
CATL Stock Hits Record High After Q1 2025 Earnings Surge 
Federal Judge Dismisses DOJ Lawsuit Attempting to Block Hawaii's Climate Case Against Oil Giants 
SK Hynix Shares Hit Record High Amid AI Memory Demand Surge 
Pentagon Taps Auto Giants to Supercharge U.S. Weapons Production 
NiSource Signs Long-Term Energy Deals with Alphabet and Amazon to Power Indiana Data Centers 
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand 
CSN's Cement Unit Sale Could Exceed $2 Billion as Global Giants Circle 
Tesla's Terafab: AI Chip Factory Eyes Taiwan's Semiconductor Talent 
Qantas Raises Fuel Cost Forecast Amid Middle East Oil Crisis 
Samsung Races to Deliver Next-Gen HBM4E Memory Samples to Nvidia 
Texas AG Investigates Lululemon Over "Forever Chemicals" in Activewear 
MENLO PARK, Calif., April 05, 2016 -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at the 15th Annual Needham Healthcare Conference in New York at 8:40 a.m. Eastern Time on Tuesday, April 12, 2016.
A live webcast of the presentation will be available through the Investor Relations pages of Geron’s website and at http://wsw.com/webcast/needham76/gern. Following the live presentation, the webcast will be archived and available for replay at the same address for a period of 30 days.
About Geron
Geron is a clinical stage biopharmaceutical company focused on the collaborative development of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.
CONTACT: Anna Krassowska, Ph.D. Investor and Media Relations 650-473-7765 [email protected] [email protected]
